Annovis Bio, Inc(NYSE:ANVS) 
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chron...
Website: http://www.qrpharma.com
Founded: 2008
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.36
H 1.37
L 1.28
C 1.30
V 248,591
10EMA 1.30
20EMA 1.30
60EMA 1.30
120EMA 1.30
250EMA 1.30